Moreover, genetic variations in the Cyclin-dependent kinase inhibitor 2A (CDKN2A) gene, and melanocortin 1 receptor (MC1R) genetic polymorphisms are associated with an increased risk of developing melanoma. The gene discussed is CDKN2A; the disease is melanoma.